"Noahber" blood bank centrifuge for in vitro diagnostics (unsterilized)
Taiwan·Risk Class 1·NOVAPRO Co., Ltd.·Registered Apr 30, 2020 – Apr 30, 2025Cancelled- Analysis ID
- cf88e7b36158905f746141e8c25f0d66
- Customs Code
- DHA09402150000
- Manufacturer
- NOVAPRO Co., Ltd.
- Manufacturer Country
- Korea, Republic of
- Authorized Representative
- SCN TRADING COMPANY LIMITED
- Intended Use
- Limited to the first level identification range of blood bank centrifuge (B.9275) for in vitro diagnostic of medical equipment management methods.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9275 Blood bank centrifuge for in vitro diagnostics
- Import Information
- QMS/QSD;; 輸入
- Registration Date
- Apr 30, 2020
- Expiry Date
- Apr 30, 2025
- Cancellation Date
- Sep 30, 2021
- Status
- Logged out
- Reason
- 轉為登錄字號
Top companies providing products similar to ""Noahber" blood bank centrifuge for in vitro diagnostics (unsterilized)"
Recently registered similar products
Access comprehensive regulatory information for "Noahber" blood bank centrifuge for in vitro diagnostics (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number cf88e7b36158905f746141e8c25f0d66 and manufactured by NOVAPRO Co., Ltd.. The authorized representative in Taiwan is SCN TRADING COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including NOVAPRO Co., Ltd., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.